Analysts say deteriorating market conditions and a deliberate push into data centers have turned one of D.C.'s most prominent ...

GOP gubernatorial candidate Bruce Blakeman blasted Gov. Kathy Hochul for enabling Mayor Zohran Mamdani — calling the pair ...

B.C.'s condo bailout may be coming. But it has not arrived yet, and the terms, when they do, may surprise everyone.

As launch rates soar, a recent NASA report finds aging infrastructure and funding gaps at Kennedy Space Center could threaten ...

Tomorrow is the first of our First Alert Weather Days this week, so get ready for some dangerous heat by tomorrow afternoon.

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) (MINISO, MINISO Group or the Company), a global high-growth value ...

Corporate legal departments at public and private companies are confronting a novel insider trading problem — one for which their existing ...

Baltimore City Council President Zeke Cohen says he’s “very concerned” about the city’s main streets and that there’s a lot ...

For more than two decades, photographer, filmmaker and author Pete McBride has followed the Colorado River from its headwaters to its tributaries, documenting one of the American West’s most important ...

Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.

About Artiva Biotherapeutics Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune ...